共 39 条
[1]
Bao X., Wang Z., Fang J., Li X., Structural features of an immunostimulating and antioxidant acidic polysaccharide from the seeds of Cuscuta chinensis, Planta Med, 68, pp. 237-243, (2002)
[2]
Beal M.F., Oxidatively modified proteins in aging and disease, Free Radic Biol Med, 32, pp. 797-803, (2002)
[3]
Bernheimer H., Birkmayer W., Hornykiewicz O., Jellinger K., Seitelberger F., Brain dopamine and the syndromes of Parkinson and Huntington. clinical, morphological and neurochemical correlations, J Neurol Sci, 20, pp. 415-455, (1973)
[4]
Block M.L., Zecca L., Hong J.S., Microglia-mediated neurotoxicity: uncovering the molecular mechanisms, Nat Rev Neurosci, 8, pp. 57-69, (2007)
[5]
Chiueh C.C., Krishna G., Tulsi P., Obata T., Lang K., Huang S.J., Murphy D.L., Intracranial microdialysis of salicylic acid to detect hydroxyl radical generation through dopamine autooxidation in the caudate nucleus: effects of MPP+, Free Radic Biol Med, 13, pp. 581-583, (1992)
[6]
Choi D.K., Et al., Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson’s disease in mice, J Neurosci, 25, pp. 6594-6600, (2005)
[7]
Chung Y.C., Et al., Fluoxetine prevents MPTP-induced loss of dopaminergic neurons by inhibiting microglial activation, Neuropharmacology, 60, pp. 963-974, (2011)
[8]
Dauer W., Przedborski S., Parkinson’s disease: mechanisms and models, Neuron, 39, pp. 889-909, (2003)
[9]
Dexter D.T., Jenner P., Parkinson disease: from pathology to molecular disease mechanisms, Free Radic Biol Med, 62, pp. 132-144, (2013)
[10]
Fahn S., Cohen G., The oxidant stress hypothesis in Parkinson’s disease: evidence supporting it, Ann Neurol, 32, pp. 804-812, (1992)